SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
1-Year Est. Return
40.04%
1 Year Est. Return
+40.04%
AUM
$103M
AUM Growth
-$21.1M
(-17%)
Holding
75
Top Buys
| 1 | +$7.85M | |
| 2 | +$1.83M | |
| 3 | +$1.73M | |
| 4 |
Edesa Biotech
EDSA
|
+$1.68M |
| 5 |
Enanta Pharmaceuticals
ENTA
|
+$1.43M |
Top Sells
| 1 | +$2.87M | |
| 2 | +$2.66M | |
| 3 | +$1.56M | |
| 4 |
Verastem
VSTM
|
+$1.55M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
+$1.23M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
ANI Pharmaceuticals
ANIP
$2.02B
| $13.6M | 13.28% |
48,000
+27,600
|
|
||
2
Evolus
EOLS
$425M
| $13.6M | 13.28% |
1,134,574
-130,077
|
|
||
|
OPTN
3
DELISTED
OptiNose
OPTN
| $7.23M | 7.04% |
788,647
+199,990
|
|
||
4
Zevra Therapeutics
ZVRA
$496M
| $4.87M | 4.74% |
650,000
+52,300
|
|
||
|
5
Verastem
VSTM
$539M
| $3.7M | 3.6% |
613,000
-257,000
|
|
||
6
UroGen Pharma
URGN
$1.08B
| $3.69M | 3.59% |
333,400
+9,076
|
|
||
7
Surrozen
SRZN
$105M
| $3.33M | 3.24% |
285,782
+148,582
|
|
||
8
Anika Therapeutics
ANIK
$142M
| $3.26M | 3.17% |
206,639
-31,583
|
|
||
|
9
Enanta Pharmaceuticals
ENTA
$317M
| $3.26M | 3.17% |
590,742
+258,842
|
|
||
10
Aquestive Therapeutics
AQST
$737M
| $3.04M | 2.96% |
200,000
+40,000
|
|
||
11
Establishment Labs
ESTA
$1.88B
| $3.04M | 2.96% |
74,500
-5,502
|
|
||
12
Indivior
INDV
$3.91B
| $2.9M | 2.82% |
304,000
-1,000
|
|
||
13
Aclaris Therapeutics
ACRS
$251M
| $2.77M | 2.69% |
527,842
-135,563
|
|
||
14
Day One Biopharmaceuticals
DAWN
$999M
| $2.77M | 2.69% |
348,820
+113,820
|
|
||
15
Xoma
XOMA
$401M
| $2.59M | 2.52% |
129,813
+4,113
|
|
||
16
TELA Bio
TELA
$46.4M
| $2.51M | 2.44% |
2,055,225
-297,874
|
|
||
17
Galapagos
GLPG
$2.08B
| $2.36M | 2.3% |
93,968
-106,032
|
|
||
18
Inhibikase Therapeutics
IKT
$112M
| $2M | 1.95% |
914,973
-217,415
|
|
||
19
Heron Therapeutics
HRTX
$202M
| $1.75M | 1.7% |
796,100
+96,100
|
|
||
|
20
Edesa Biotech
EDSA
$12.6M
| $1.68M | 1.63% |
+687,500
|
|
||
21
Myomo
MYO
$32.3M
| $1.33M | 1.3% |
276,707
+2,281
|
|
||
22
Keros Therapeutics
KROS
$494M
| $1.02M | 0.99% |
+100,000
|
|
||
23
Vir Biotechnology
VIR
$714M
| $937K | 0.91% |
144,628
-19,478
|
|
||
|
SCPH
24
DELISTED
scPharmaceuticals
SCPH
| $914K | 0.89% |
347,687
-335,843
|
|
||
25
Inovio Pharmaceuticals
INO
$113M
| $845K | 0.82% |
518,331
-531,669
|
|